#STOPHAYFEVER
Enquiries / Booking
0207 435 8171

Publications & Research

Clinical Excellence Award-UCLH 2017
(outstanding research, teaching, clinical care recognition)

PhD Thesis Prize
(most outstanding student & thesis)
NHL1
Imperial College London 2008

Imperial College London Trust Fund
Clinical Research Fellowship 2003

Chronic rhinosinusitis: eosinophil blood reference values and decision limits and tissue count intravariability.
Baoran Yang, Magdalena Dziadzio, Marta Meridamorillas, Jonathan A Joseph, Simon B Gane 2,3, Louisa K James, Kariyawasam HH.

Clinical Otolaryngology (submitted).

Chronic rhinosinusitis with and without nasal polyps and asthma : omalizumab improves residual anxiety but not depression
Florian Vogt, Jagdeep Sahota, Therese Bidder, Rebecca Livingston, Helene Bellas, Simon B Gane, Valerie J Lund, Douglas S Robinson, Kariyawasam HH.
Clinical and Translational Allergy (in press).

Chronic rhinosinusitis with nasal polyps in patients with aspirin sensitivity-mycophenolate mofetil is an effective steroid-sparing agent.
Kariyawasam HH, Leandro M, Dziadzio M, Robinson DS, Lund VJ, Gane SB.
JAMA Otolaryngol Head Neck Surg. 2020 Oct 8.

European position paper on rhinosinusitis and nasal polyps 2020.
Fokkens WJ, Lund VJ, Hopkins C… Kariyawasam HH …Zwetsloot CP.
Rhinology. 2020 Feb 20;58(Suppl S29):1-464

Chronic rhinosinusitis and omalizumab: eosinophils not IgE predict treatment response in real-life.
Sahota J, Bidder T, Livingston R…Kariyawasam HH.
Rhinology Online, Vol 1: 147 - 153, 2018.

Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.
Bidder T, Sahota J, Rennie C, Lund VJ, Robinson DS, Kariyawasam HH.
Rhinology. 2017 Dec 30

BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007)
Scadding GK, Kariyawasam HH et al.
Clinical & Experimental Allergy 07/2017; 47(7):856-889.

Reduced need for surgery in severe nasal polyposis with mepolizumab: a randomized trial.
Claus Bachert, Ana R. Sousa, Valerie J. Lund, Glenis K. Scadding, Philippe Gevaert, Shuaib Nasser, Stephen R. Durham, Marjolein E. Cornet, Kariyawasam HH, Jane Gilbert, Daren Austin, Aoife C. Maxwell, Richard P. Marshall, Wytske J. Fokkens.
J Allergy Clin Immunol. 2017 Oct; 140(4):1024-1031

Antibodies and superantibodies in chronic rhinosinusitis with nasal polyps
Jiun-Bo Chen, Louisa K. James, Anna M. Davies, Y-C Wu, Joanne Rimmer, Valerie J. Lund, Jou-Han Chen, James M McDonnell Yih-Chih Chan, Tse Wen Chang, Brian J. Sutton,
Kariyawasam HH, Gould HJ.
J Allergy Clin Immunol. 2016 Sep 19. S0091-6749(16)30967-8 (AAAAI selected to read as of outstanding interest)

IL-25/IL-33 responsive oligoclonal Th2 cells characterize nasal polyps with Th17 as the default healthy nasal mucosal signature
Lam EPS, Kariyawasam HH et al.
J Allergy Clin Immunol. 2016 May; 137(5):1514-24

Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes
Samitas K, Poulos N, Semitekolou M, Morianos I, Tousa S, Economidou E, Robinson DS, Kariyawasam HH, Zervas E, Corrigan CJ, Ying S, Xanthou G and Gaga M.
Eur Respir J. 2016 Mar; 47(3):769-82

Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps.
Gevaert P, Nouri-Aria KT, Wu H, Harper CE, Takhar P, Fear DJ, Acke F, De Ruyck N, Banfield Kariyawasam HH, Bachert C, Durham SR, Gould HJ.
Allergy. 2013 Jan; 68(1):55-63.

Deficient transforming growth factor (TGF)-β1 receptor expression in mild asthma.
Kariyawasam HH, Barkans J, Aizen M, Ying S, Xanthou G, Lloyd CM, Kay AB, Robinson DS.
Proc. 28th Symposium CIA 169-172 2012

The effects of an anti-IL-13 monoclonal antibody on cytokine levels and nasal symptoms following nasal allergen challenge.
Nicholson GC, Kariyawasam HHet al.
J Allergy Clin Immunol. 2011 Oct; 128(4):800-807

Expression of functional receptor activity modifying protein 1 by airway epithelial cells with dysregulation in asthma
Bonner K, Kariyawasam HH, Ali FR, Clark P, Kay AB
J Allergy Clin Immunol. 2010 Dec; 126(6):1277-83

** High-lighted as the editor’s choice

Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma.
Kariyawasam HH, Pegorier S, Barkans J, Xanthou G, Aizen M, Ying S, Kay AB, Lloyd CM, Robinson DS.
J Allergy Clin Immunol. 2009 Sep; 124(3):454-62.

Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma.
Reynolds C, Barkans J, Clark P, Kariyawasam HH, Altmann D, Kay B, Boyton R.
J Allergy Clin Immunol. 2009 Oct; 124(4):860-2

Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease.
Semitekolou M, Alissafi T, Aggelakopoulou M, Kourepini E, Kariyawasam HH, Kay AB, Robinson DS, Lloyd CM, Panoutsakopoulou V, Xanthou G.
J Exp Med. 2009 Aug 3; 206(8):1769-85

Basal expression of bone morphogenetic protein (BMP) receptor is reduced in asthma Kariyawasam HH, Xanthou G, Barkans J, Aizen M, Kay AB, Robinson DS
Am J Resp Crit Care Med, 2008 May 15; 177(10):1074-81.

Safety and tolerability of three consecutive bronchoscopies in mild asthmatic volunteers after allergen challenge
Kariyawasam HH, Aizen M, Barkans J, Kay AB, Robinson DS
Thorax, 2007 Jun; 62(6):557-8.

Remodeling and airway hyperresponsiveness but not cellular inflammation persists after allergen challenge in asthma.
Kariyawasam HH, Aizen M, Barkans J, Robinson DS, Kay AB**
Am J Respir Crit Care Med. 2007 May 1; 175(9): 896-904.

** Prof. Richard F. Lockey, MD, World Allergy Organisation (WAO) Web Editor-in-Chief, reviewed premier medical journal articles for practicing allergists in 2007 and this work was selected as one of his top four picks to read (ref: WAO News & Notes - July 2007 Volume 4, Issue 7). This is an important study as it is the first human model of airway fibrosis and is the first study to show that airway hyper-responsiveness can be dissociated from inflammation but not tissue fibrosis.

Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure
B.P. Madden, Kariyawasam HH, A.J. Siddiqi, A. Machin J.A. Pryor, M.E. Hodson
Eur Respir J, 2002 Feb; 19(2):310-3.

Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7.
Pflugers Arch. 2001; 443 Suppl 1:S55-61.
Shori D, Genter T, Hansen J, Koch C, Wyatt H, Kariyawasam HH, Knight R, Hodson
M, Kalogeridis A, Tsanakas I

Sulphation of the salivary mucin MG1 (MUC-5B) is not correlated to the degree of its sialylation and is unaffected by cystic fibrosis.
Shori D Kariyawasam HH, Knight R, Hodson M, Genter T, Hansen J, Koch C, A.
Kalogeridis A
Pflugers Arch. 2001; 443 Suppl 1:S50-4.

Experience of totally implantable venous access devices (TIVADs) in adults with cystic fibrosis over a 13-year period.
Kariyawasam HH, Pepper JR, Hodson ME, Geddes DM
Respir Med. 2000 Dec; 94(12):1161-5.

Anaemia in lung transplant patient caused by parvovirus B19.
Kariyawasam HH,
Gyi KM, Hodson ME, Cohen BJ
Thorax. 2000 Jul; 55(7):619-20.

B cells and upper airway disease: allergic rhinitis and chronic rhinosinusitis with nasal polyps evaluated
Kariyawasam HH, James LK
Expert Rev Clin Immunol (submitted) 2021

Chronic rhinosinusitis with nasal polyps: targeting IgE with anti-IgE omalizumab therapy
Kariyawasam HH,  James LK
Drug Des Devel Ther. 2020 Dec 10;14:5483-5494. 

Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab
Kariyawasam HH
Expert Rev Clin Immunol. 2020 Dec;16(12):1115-1125.

Dupilumab: clinical efficacy of blocking IL-4/IL-13 signalling in chronic rhinosinusitis with nasal polyps
Kariyawasam HH, James LK, Gane SB
Drug Des Devel Ther. 2020 May 8;14:1757-1769.

Allergen-induced asthma, chronic rhinosinusitis and transforming growth factor-β superfamily signaling: mechanisms and functional consequences
Kariyawasam HH, Gane SB
Expert Rev Clin Immunol. 2019 Nov;15(11):1155-1170.

Chronic rhinosinusitis with nasal polyps: insights into mechanisms of disease from emerging biological therapies
Kariyawasam HH
Expert Rev Clin Immunol. 2019 Jan;15(1):59-71

Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited
Samitas K, Carter A, Kariyawasam HH, Xanthou G
Allergy. 2017 Dec 1

Phase three studies of biologics for severe asthma: could do better?
Robinson DS, Kariyawasam HH, Heaney LG
Eur Respir J. 2017 Sep 12; 50

Chronic rhinosinusitis: back to the future?
Kariyawasam HH and Dziadzio
ENT and Audiology News July/August 2016 Vol 25 No 3

An update in the management of allergic rhinitis
Kariyawasam HH, Joanna Lukawska and Giuseppina Rotiroti
The Otorhinolaryngologist 2016

Mepolizumab for eosinophilic severe asthma: recent studies.
Robinson DS, Kariyawasam HH
Expert Opin Biol Ther. 2015 Jun;15(6):909-14

Sublingual immunotherapy in allergic rhinitis: indications, efficacy and safety
Kariyawasam HH, Rotiroti G, Robinson
Rhinology. 2013 Mar;51(1):9-17

Allergic rhinitis, chronic rhinosinusitis and asthma: unravelling a complex relationship.
Kariyawasam HH, Rotiroti G
Curr Opin Otolaryngol Head Neck Surg. 2013 Feb; 21(1):79-86.

Chronic rhinosinusitis: therapeutic efficacy of anti-inflammatory and antibiotic approaches.
Kariyawasam HH, Scadding GK
Allergy Asthma Immunol Res. 2011 Oct; 3(4):226-35.

Activin-A: a novel critical regulator of allergic asthma ***.
Kariyawasam HH, Semitekolou M, Robinson DS, Xanthou G

*** Selected by Global Medical Discovery (Ontario Canada) as of outstanding interest for drug development in disease.

Clin Exp Allergy. 2011 Nov; 41(11):1505-14 

Airway remodelling in asthma: mechanisms and clinical significance
Kariyawasam HH
Respiratory Medicine CML Volume 2010 Vol 24 Issue 2 (Leading Article)

Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated    
Kariyawasam HH, Scadding GK
J Asthma Allergy 2010: 3 19–28

Airways disease: just nosing around?
Scadding GK, Kariyawasam HH   
Thorax. 2009 Nov; 64(11):923-5.

Developments in the field of allergy in 2008 through the eyes of Clinical & Experimental Allergy
Almqvist C, Bradding PB, Chakir J, Ebo D, Grattan C, Kariyawasam HH et al.
Clin Exp Allergy. 2009 Oct; 39(10):1482-98.

The role of eosinophils in airway tissue remodelling in asthma.
Kariyawasam HH, Robinson DS
Curr Opin Immunol, 2007 Dec; 19(6): 681-6.

The eosinophil: the cell and its weapons, the cytokines, its locations
Kariyawasam HH, Robinson DS
Semin Respir Crit Care Med. 2006 Apr; 27(2): 117-27.

Airway remodelling in asthma: models and supermodels?
Kariyawasam HH, Robinson DS
Clin Exp Allergy. 2005 Feb; 35(2):117-21.

Allergic Rhinitis
Encyclopaedia of Respiratory Medicine. Ed: Janes S.
Elsevier Limited, Oxford, UK (2021) (in press)
Kariyawasam HH, Rotiroti G

Eosinophils
Encyclopaedia of Respiratory Medicine. Ed: Janes S.
Elsevier Limited, Oxford, UK (2021) (submitted)
Kariyawasam HH

The relationship between the upper and lower airway - an ENT perspective
J ENT Master Class 2014; 7(1): 65-69
Kwame I and Kariyawasam H

Steroids in otorhinolaryngology
Diagnosis and Treatment of Voice Disorders
Eds Rubin JR (2013)
Kariyawasam HH, Rotiroti G, Lloyd SW

Medications and the Voice
Diagnosis and Treatment of Voice Disorders
Eds Rubin JR (2013)
Harris TM, Kariyawasam HH, Rubin JR

Human Studies of Remodelling and Fibrosis in Asthma and Allergic Inflammation
Eosinophils in Health and Disease 2012
Eds Lee J and Rosenberg H
Kariyawasam HH, Robinson DS, Kay AB

Upper Airway Disease: Rhinitis and Rhinosinusitis
Clinical Respiratory Medicine 2012
Eds Spiro, Silvestri & Agusti
Scadding GS, Kariyawasam HH

Eosinophils
Encyclopaedia of Respiratory Medicine. Eds: Laurent G L and Shapiro S.
Elsevier Limited, Oxford, UK (2006)
Kariyawasam HH, D S Robinson

Best of Five Clinical Scenarios for the MRCP Part I
Respiratory Medicine, Medexam series, Greenwich Medical Media, 2004
Kariyawasam HH

Unusual cause of throat swelling in an allergy clinic
Hosadurg D, Miron R, Lukawska, Kariyawasam HH, Rotiroti G, Radcliffe M, Dziadzio
EAACI Helsinki 2017

Chronic Rhinosinusitis Associated with Alpha 1 antitrypsin deficiency
Baker J, Ferguson M, Miron R, Lukawska, Rotiroti G, Rajkulasingham R, Kariyawasam HH, Dziadzio M.
EAACI Helsinki 2017

Effects of Omalizumab on nasal symptoms (SNOT score) in patients treated for severe asthma
J.Sahota, T.Bidder, J.Solis, Kariyawasam HH, Robinson D
ERS AGM Milan 2017

Chronic rhinosinusitis with nasal polyps (CRSwNP): mycophenolate mofetil (MMF) is an effective steroid sparing treatment strategy
Nada Al-Barani, Maria Leandro, Douglas S Robinson, Valerie J Lund, Kariyawasam HH
Stockholm ERS 2016

Refractory neurogenic rhinitis: treatment with amitriptyline
Juan Meng, Giuseppina Rotiroti, Joanna Lukawska, Valerie J Lund, Kariyawasam HH
Stockholm ERS 2016

Overcoming barriers to penicillin allergy un-labelling
N.A. Bahrani, D. Thursfield, Kariyawsam HH and J. Lukawska
Telford BSACI AGM

Is there a doctor on board?
A. Foggitt, N. Verma, D. Thursfield, Kariyawasam HH, N.A. Bahrani, M. Dziadzio1 and J. Lukawska, Telford BSACI AGM

Reviewing Penicillin allergy labels is good for patient’s health & hospital’s bank balance
A.Murugesh-Warren… Kariyawasam HH and Lukawska J
Telford BSACI AGM 2015

Clavulanic acid anaphylaxis – more common than you might think
Thursfield D, Kariyawasam HH et al.
Telford BSACI AGM 2015

Evaluation of a food challenge service in relation to specific IgE to molecular components in children with suspected peanut allergy
James Gardner, Minal Gandhi, Kariyawasam HH and Giuseppina Rotiroti PAM Istanbul 2015

CD4 (+) T Cells From Nasal Polyp Explants Contain Abundant Th2 Cells Expressing Functional Interleukin-25 Receptors Together With Th17 Cells.     
Lam, E; Kariyawasam, HH; Durham, SR; Rimmer, J; Lund, VJ; Cousins, D; Till, S

Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI).
San Diego 2014
Camara M, Kariyawasam HH

Inverse correlation of nasal polyp size with Vitamin D Serum Levels
Clin. Exp.Allergy 2011 and BSACI 2011 AG
Samitas K, Kariyawasam HH, Xanthou G, Gaga M

Activin-A is increased in severe asthma and involved in tissue angiogenesis
Euro Resp J 2012
Kay AB, Bonner K, Kariyawasam HH, Ali FR, Clark Pet al.

2010, Expression of Functional Receptor Activity Modifying Protein (RAMP)-1 by Airway Epithelial Cells with Dysregulation in Asthma
British-Thoracic-Society-Winter-Meeting 2010, Publisher: B M J PUBLISHING GROUP, Pages: A21-A21, ISSN: 0040-6376
Kariyawasam HH, Nicholson GC, Synga Nl, Kon OM, Barnes PJ, Hansel TT

The effects of a monoclonal antibody against IL-13 (Novartis QAX576) on inflammatory responses following repeated nasal allergen challenge (NAC) in subjects with hay fever outside the grass pollen season
Am J Resp Crit Care Med 2007; 177
Kariyawasam HH, Barkans J, Aizen M, Kay AB, Robinson DS

Airway submucosal cells expressing TGF-ß1 are significantly increased at a time point when airway remodelling is maximal post-allergen
Am J Resp Crit Care Med 2007; 177
Tan AJ, Kariyawasam HH, Nicholson NC, Synga N et al.

Nasal challenge with hypertonic saline (HTS) and assessment of neural reflex activation           
Am J Resp Crit Care Med 2007; 177:
Kariyawasam HH, Aizen M, Barkans J, Robinson DS, Kay AB

Increased remodelling and airway hyper responsiveness but not inflammation persists after allergen challenge in asthma.
Am J Resp Crit Care Med 2007; 175: A833.
Kariyawasam HH, Xanthou G, Barkans J, Sideras P, Kay AB, Robinson DS.

Dysregulated Bone morphogenetic protein (BMP) signalling in allergen-induced asthma
Am J Resp Crit Care Med 2007; 175: A833.
Kariyawasam HH, Xanthou G, Barkans J, Ying S,  Sideras P, Kay AB, Robinson D

Activation and modulation of TGF-beta and activin signalling pathways in allergen-induced
Asthma Am J Resp Crit Care Med 2007; 175: A834.
Kariyawasam HH, M. Aizen, J. Barkans, A.B. Kay, D.S. Robinson.

Persistence of airway hyper-responsiveness (AHR) after resolution of bronchial mucosal inflammation following allergen inhalation challenge in mild asthmatics 
American Academy of Asthma, Allergy and Immunology Miami 2006
J Allergy Clin Immunol 2006; 117:S158 (abs 1086)
Shori DK, Blackett S, Hansen J, Genter G, Kariyawasam HH, Kalogeridis A, Knight R, Koch C

Altered siayl-linkage on key mucins may relate to severity of lung disease in cystic fibrosis.
24th European Cystic Fibrosis Conference, Stockholm, Sweden 2000]
Shori DK, Blackett S, Kariyawasam HH et al.

Altered glycosylation of salivary mucins in cystic fibrosis and its correlation to lung disease.
The First International Conference on the Secretion Defect in Cystic Fibrosis, Greece. 1999
Kariyawasam HH, Hodson ME, Geddes DM.

Experience of transplantable intravenous access devices (TIVADs) in adults with cystic fibrosis: incidence and types of complications.
23rd European Cystic Fibrosis Conference, Hague Netherlands, 1999
Kariyawasam HH, Stirling RG, Campbell DA, Robinson DS Chung KF, Carr D.

Demonstration of air trapping by high resolution computer tomography (HRCT) in difficult asthma.
European Respiratory Society Annual Congress, Madrid, 1999 (publication as supplement to ERJ. 1999)
Madden BP, Kariyawasam HH, Hodson ME.

Nasal Ventilation in Cystic Fibrosis - The Bridge to Transplantation
European Respiratory Society Annual Congress, Madrid, Spain, October 1999 (publication as supplement to ERJ 1999).

Affordable hay fever treatment

For enquiries and booking
0207 435 8171

Book Online Now